设为首页收藏本站
开启辅助访问 切换到窄版

 找回密码
 To register

QQ登录

只需一步，快速开始

扫一扫，访问微社区

  • ALL
  • Journals
  • Books

派博传思国际中心 »期刊书目

› Journal of SCIE
› CARDIAC & CARDIOVASCULAR SYSTEMS(心脏与心血管系统)

1234下一页
返回列表

SCIE期刊Cardiovascular Therapeutics 2024/2025影响因子:3.404 (CARDIOVASC THER) (1755-5914). (CARDIAC & CARDIOVASCULAR SYSTEMS)

[复制链接]
查看: 13399|回复: 35
发表于 2025-3-21 18:15:26 | 显示全部楼层 |阅读模式
期刊全称Cardiovascular Therapeutics
期刊简称CARDIOVASC THER
影响因子20243.404
视频videohttp://file.papertrans.cn/5/4788/4788.mp4
ISSN1755-5914
eISSN1755-5922
出版商WILEY
发行地址111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774
学科分类1.Science Citation Index Expanded (SCIE)--Cardiac & Cardiovascular System | Pharmacology & Pharmacy; 2.Biological Abstracts--Cardiac & Cardiovascular System | Pharmacology & Pharmacy; 3.BIOSIS Previews_BIOSIS Citation Index--Cardiac & Cardiovascular System | Pharmacology & Pharmacy; 4.Current Contents Clinical Medicine--Cardiovascular & Respiratory Systems; 5.Essential Science Indicators--Pharmacology & Toxicology;
出版语言English
The information of publication is updating

SCIE(SCI)期刊Cardiovascular Therapeutics(20 21 REV HIST)影响因子


SCIE(SCI)期刊Cardiovascular Therapeutics(CARDIOVASC THER)影响因子@(心脏与心血管系统)学科排名


SCIE(SCI)期刊Cardiovascular Therapeutics(20 21 REV HIST)总引论文


SCIE(SCI)期刊Cardiovascular Therapeutics(CARDIOVASC THER)总引论文@(心脏与心血管系统)学科排名


SCIE(SCI)期刊Cardiovascular Therapeutics(20 21 REV HIST)影响因子


SCIE(SCI)期刊Cardiovascular Therapeutics(CARDIOVASC THER)总引频次@(心脏与心血管系统)学科排名


SCIE(SCI)期刊Cardiovascular Therapeutics(20 21 REV HIST)即时影响因子


SCIE(SCI)期刊Cardiovascular Therapeutics(CARDIOVASC THER)即时影响因子@(心脏与心血管系统)学科排名


SCIE(SCI)期刊Cardiovascular Therapeutics(20 21 REV HIST)五年累积影响因子


SCIE(SCI)期刊Cardiovascular Therapeutics(CARDIOVASC THER)五年累积影响因子@(心脏与心血管系统)学科排名


单选投票, 共有 1 人参与投票
1.jpg
 

0票 0.00%

Perfect with Aesthetics
2.jpg
 

1票 100.00%

Better Implies Difficulty
3.jpg
 

0票 0.00%

Good and Satisfactory
4.jpg
 

0票 0.00%

Adverse Performance
5.jpg
 

0票 0.00%

Disdainful Garbage
您所在的用户组没有投票权限
HEM
回复

举报

发表于 2025-3-21 21:18:47 | 显示全部楼层
Submitted on: 04 January 2024. Revised on: 23 April 2024. Accepted on: 13 May 2024. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI
确定无疑
回复

举报

发表于 2025-3-22 03:53:10 | 显示全部楼层
Submitted on: 19 December 2002. Revised on: 14 March 2003. Accepted on: 01 April 2003. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI
奇怪
回复

举报

发表于 2025-3-22 04:47:13 | 显示全部楼层
Submitted on: 30 August 2012. Revised on: 15 November 2012. Accepted on: 27 December 2012. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI
Crohns-disease
回复

举报

发表于 2025-3-22 10:39:49 | 显示全部楼层
Submitted on: 13 September 2019. Revised on: 08 January 2020. Accepted on: 26 February 2020. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI
Wallow
回复

举报

发表于 2025-3-22 14:53:46 | 显示全部楼层
Submitted on: 22 August 1999. Revised on: 08 December 1999. Accepted on: 02 February 2000. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI
体贴
回复

举报

发表于 2025-3-22 21:01:32 | 显示全部楼层
Submitted on: 14 November 2023. Revised on: 18 January 2024. Accepted on: 13 March 2024. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI
Metamorphosis
回复

举报

发表于 2025-3-23 00:15:52 | 显示全部楼层
Submitted on: 14 December 2010. Revised on: 15 February 2011. Accepted on: 04 April 2011. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI
人类的发源
回复

举报

发表于 2025-3-23 04:19:58 | 显示全部楼层
Submitted on: 08 March 2021. Revised on: 01 July 2021. Accepted on: 16 August 2021. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI
不发音
回复

举报

发表于 2025-3-23 09:07:26 | 显示全部楼层
Submitted on: 25 July 2003. Revised on: 24 September 2003. Accepted on: 16 October 2003. ___________________Cardiovascular Therapeutics---WILEY-HINDAWI
强壮
回复

举报

下一页 »
1234下一页
返回列表
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-12-19 19:48
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表